Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10035131HBVENSG00000074803.21protein_codingSLC12A1NoNo6557Q13621
Q8IUN5
TVIS20002358HPVENSG00000074803.21protein_codingSLC12A1NoNo6557Q13621
Q8IUN5
TVIS20038461HPVENSG00000074803.21protein_codingSLC12A1NoNo6557Q13621
Q8IUN5
TVIS20052244HPVENSG00000074803.21protein_codingSLC12A1NoNo6557Q13621
Q8IUN5
TVIS20025243HPVENSG00000074803.21protein_codingSLC12A1NoNo6557Q13621
Q8IUN5
TVIS44002636HTLV-1ENSG00000074803.21protein_codingSLC12A1NoNo6557Q13621
Q8IUN5
TVIS44029374HTLV-1ENSG00000074803.21protein_codingSLC12A1NoNo6557Q13621
Q8IUN5
TVIS44010135HTLV-1ENSG00000074803.21protein_codingSLC12A1NoNo6557Q13621
Q8IUN5
TCGA Plot Options
Drug Information
GeneSLC12A1
DrugBank IDDB00887
Drug NameBumetanide
Target IDBE0000502
UniProt IDQ13621
Regulation Typeinhibitor
PubMed IDs10561751; 9587066; 9690036; 11752352; 19141616
CitationsThakker RV: Chloride channels in renal disease. Adv Nephrol Necker Hosp. 1999;29:289-98.@@Karolyi L, Koch MC, Grzeschik KH, Seyberth HW: The molecular genetic approach to "Bartter's syndrome". J Mol Med (Berl). 1998 Apr;76(5):317-25.@@Thakker RV: The role of renal chloride channel mutations in kidney stone disease and nephrocalcinosis. Curr Opin Nephrol Hypertens. 1998 Jul;7(4):385-8.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Long P, Mercer A, Begum R, Stephens GJ, Sihra TS, Jovanovic JN: Nerve Terminal GABAA Receptors Activate Ca2+/Calmodulin-dependent Signaling to Inhibit Voltage-gated Ca2+ Influx and Glutamate Release. J Biol Chem. 2009 Mar 27;284(13):8726-37. doi: 10.1074/jbc.M805322200. Epub 2009 Jan 13.
GroupsApproved
Direct ClassificationDiphenylethers
SMILESCCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O
PathwaysBumetanide Action Pathway
PharmGKBPA448682
ChEMBLCHEMBL1072